Glenview Capital Submits Documentation Confirming Shareholders Have Approved All Consents Necessary to Revitalize HMA

 Glenview Capital Submits Documentation Confirming Shareholders Have Approved
                   All Consents Necessary to Revitalize HMA

Glenview Thanks Fellow Shareholders for Supporting Efforts To Build Value,
Quality and Culture

PR Newswire

NEW YORK, Aug. 12, 2013

NEW YORK, Aug. 12, 2013 /PRNewswire/ --Glenview Capital Management LLC, which
owns 14.6% of the common stock of Health Management Associates, Inc. (NYSE:
HMA) through affiliated investment funds, today issued the following
statement:

"Earlier today, Glenview submitted to the appropriate representatives of HMA
documentation that a majority of shareholders have voted for the removal and
replacement of the entire Board of Directors at HMA. We anticipate that the
Sitting HMA Board will work with their outside advisors to ensure a prompt
fiduciary review of the voting results. Led by future HMA Chairman Steven
Shulman, the nominees will be in contact with the outgoing HMA Board and their
advisors to ensure a smooth transition to be effected this week.

On behalf of our investors and our team, we would like to offer our
appreciation to the many constituents of HMA:

  oTo the hard working men and women of HMA who maintained focus and
    dedication to their mission throughout this seven week process and who
    strive to improve health outcomes throughout their local communities;
  oTo fellow shareholders who took the time to consider the myriad of issues
    and who voted, based upon both financial and moral values, to take action
    to improve our Company;
  oTo the nominees of the Fresh Alternative slate of Directors who were
    willing to lend their efforts and talents despite an uncertain path and
    who will work diligently to improve our Company, and to the team at
    Alvarez & Marsal who have prepared for a responsible transition and a path
    to stabilization and improvement;
  oTo the independent advisory services of Institutional Shareholder Services
    and Glass Lewis who cut through the rhetoric to help frame and analyze the
    issues at hand, and for their support of complete change at HMA;
  oTo Akin Gump, UBS, Okapi Partners and ASC Advisors, our legal, financial,
    proxy and communications advisors; and
  oTo the Sitting Board and their advisors, in anticipation of their working
    honorably and constructively through the upcoming transition.

For a few months within our thirteenth year of operation, our firm moved
uncomfortably into the public eye in order to advance three important causes:

i) First, it is incumbent on Management, Boards and shareholders to work
constructively and methodically to improve shareholder value over time to
ensure an appropriate risk adjusted return on capital for owners. This
includes the Board's responsibility to review financial and strategic
alternatives and operational and human resource performance in an
intellectually honest manner, prioritizing shareholder returns over social or
legacy issues.

ii) Second, it is imperative that Management and Boards treat shareholders as
true partners rather than adversaries in the journey to build sustainable
value and quality enterprises.

iii) Finally, it is the responsibility of shareholders to embrace and support
change when neither of these conditions are satisfied.

We believe that these key principles brought together investors across every
category -- mutual funds, pension funds, hedge funds, individual investors
and current and former employees and retirees – to defend and promote
shareholders' rights through their consents to Revitalize HMA. We at Glenview
are proud of our efforts to improve quality, compliance, accountability and
shareholder value at HMA, and we are happy to have contributed to the broader
discourse by challenging all shareholders to think and act like owners to
promote financial and corporate success. Several months from now, with
greater Board and Management engagement and greater transparency, Glenview and
other shareholders will consider the Community Proposal with an eye towards
maximizing shareholder value and positioning HMA to best serve the healthcare
needs of its local communities."

About Glenview Capital Management

Glenview Capital Management is a private investment management firm with more
than $6 billion of assets under management. The firm was founded in 2000 and
manages capital for qualified investors through a series of private investment
funds, and has offices in New York and London. Glenview is focused on
delivering attractive absolute returns through an intense focus on deep,
fundamental research and individual security selection.

For More Information go to www.revitalizehma.com or contact:
Media:
Scott Tagliarino/Katrina Allen
ASC Advisors LLC
(203) 992-1230

Investors:
Bruce Goldfarb/ Patrick McHugh/ Lydia Mulyk
Okapi Partners LLC
(212) 297-0720
Toll Free: (877) 869-0171 

GLENVIEW CAPITAL PARTNERS, L.P., GLENVIEW CAPITAL MASTER FUND, LTD., GLENVIEW
INSTITUTIONAL PARTNERS, L.P., GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.,
GLENVIEW CAPITAL OPPORTUNITY FUND, L.P., GLENVIEW CAPITAL MANAGEMENT, LLC AND
LARRY ROBBINS (COLLECTIVELY, "GLENVIEW") TOGETHER WITH THE PROPOSED NOMINEES
(COLLECTIVELY, WITH GLENVIEW, THE "PARTICIPANTS") HAVE FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION (THE "SEC") A DEFINITIVE CONSENT STATEMENT
AND ACCOMPANYING CONSENT CARD TO BE USED TO SOLICIT WRITTEN CONSENTS FROM THE
STOCKHOLDERS OF HEALTH MANAGEMENT ASSOCIATES, INC. ("HMA" OR "THE COMPANY") IN
CONNECTION WITH GLENVIEW'S INTENT TO TAKE CORPORATE ACTION BY WRITTEN CONSENT.
ALL STOCKHOLDERS OF THE COMPANYARE ADVISED TO READ THE DEFINITIVE CONSENT
STATEMENT AND OTHER DOCUMENTS RELATED TO THE SOLICITATION OF WRITTEN CONSENTS
FROM THE STOCKHOLDERS OF THE COMPANY BY THE PARTICIPANTS BECAUSE THEY CONTAIN
IMPORTANT INFORMATION. INFORMATION RELATING TO THE PARTICIPANTS IS CONTAINED
IN THE DEFINITIVE CONSENT STATEMENT FILED ON JULY 16, 2013. THE DEFINITIVE
CONSENT STATEMENT AND FORM OF WRITTEN CONSENT ARE BEING FURNISHED TO SOME OR
ALL OF THE STOCKHOLDERS OF THE COMPANY AND ARE, ALONG WITH OTHER RELEVANT
DOCUMENTS, AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT
HTTP://WWW.SEC.GOV. IN ADDITION, GLENVIEW WILL PROVIDE COPIES OF THE
DEFINITIVE CONSENT STATEMENT AND ACCOMPANYING CONSENT CARD (WHEN AVAILABLE)
WITHOUT CHARGE UPON REQUEST TO OKAPI PARTNERS LLC, TELEPHONE: (877) 869-0171.

Cautionary Statement Regarding Forward-Looking Statements

This presentation may include "forward-looking statements" that reflect
current views of future events. Statements that include the words "expect,"
"intend," "plan," "believe," "project," "anticipate," "will," "may," "would"
and similar statements of a future or forward-looking nature are often used to
identify forward-looking statements. Similarly, statements that describe our
objectives, plans or goals are forward-looking. Glenview's forward-looking
statements are based on its current intent, belief, expectations, estimates
and projections regarding the Company and projections regarding the industry
in which it operates. These statements are not guarantees of future
performance and involve risks, uncertainties, assumptions and other factors
that are difficult to predict and that could cause actual results to differ
materially. Accordingly, you should not rely upon forward-looking statements
as a prediction of actual results and actual results may vary materially from
what is expressed in or indicated by the forward-looking statements. Except
to the extent required by applicable law, no person undertakes any obligation
to update publicly or revise any forward-looking statement, whether as a
result of new information, future developments or otherwise.

SOURCE Glenview Capital Management LLC

Website: http://www.revitalizehma.com
 
Press spacebar to pause and continue. Press esc to stop.